El Hospital "Prof. Dr. Juan P. Garrahan" es el centro pediátrico de referencia en salud pública, gratuita y de alta complejidad de la Argentina.​

During the past decade, Hospital de Pediatría Garrahan conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Pediatría Garrahan" #1 sponsor was "Hospital JP Garrahan" with 3 trials, followed by "BioMarin Pharmaceutical" with 2 trials sponsored, "Laboratorio Elea Phoenix S.A." with 2 trials sponsored, "Erasmus Medical Center" with 1 trials sponsored and "Histiocyte Society" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Pediatría Garrahan" #1 collaborator was "Alberta Children's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Child and Family Research Institute" with 1 trials as a collaborator, "Hospital Pereyra Rosell, Montevideo, Uruguay" with 1 trials as a collaborator and "Hospital Pereyra Rossell, Montevideo" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Pediatría Garrahan" are "Neuroblastoma" (2 trials), "Retinoblastoma" (2 trials), "Achondroplasia" (1 trials), "Childhood Langerhans Cell Histiocytosis" (1 trials) and "Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis)" (1 trials). Many other conditions were trialed in "Hospital de Pediatría Garrahan" in a lesser frequency.

Most popular intervention types in "Hospital de Pediatría Garrahan" are "Drug" (6 trials), "Other" (3 trials), "Combination Product" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood sampling" (1 trials), "Combination Chemotherapy plus Intrathecal Topotecan" (1 trials), "DTG +DRV/r" (1 trials), "High risk with complete early response after 1 ABVD and 1 ESHAP courses. Four more chemotherapy courses are delivered alternating ESHAP and ABVD." (1 trials) and "High risk with partial remission after 1 ABVD and 1 ESHAP courses. Six more chemotherapy courses are delivered alternating ESHAP and ABVD." (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Pediatría Garrahan" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Pediatría Garrahan". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital de Pediatría Garrahan, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Pediatría Garrahan, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".